KlenSmart60 Clenbuterol 60mcg – 50 Tablets

This formulation delivers Clenbuterol Hydrochloride at 60mcg per tablet; a notably high single tablet dose compared to CSD’s standard Clenbuterol presentations at 40mcg and 80mcg, sitting between the two but as a single fixed unit rather than splitable across the dose range typically referenced for gradual titration.

It’s worth understanding where 60mcg sits relative to typical Clenbuterol dosing patterns referenced in the available literature. Most protocols describe starting at the lower end (commonly 20mcg) and titrating gradually upward over days to weeks, both to assess individual tolerance and to manage Clenbuterol’s well documented cardiac and central nervous system side effects, which scale with dose. A 60mcg single tablet provides less flexibility for this kind of gradual approach than splitting a lower dose tablet, and represents a dose point that exceeds what most starting protocols reference.

Clenbuterol’s narrow margin between researched effects and cardiac risk applies with particular relevance at this dose; tachycardia, tremor, anxiety, and electrolyte shifts (especially potassium) are well documented even at lower doses, and the long half-life of approximately 35-40 hours means repeated dosing at 60mcg accumulates meaningfully before reaching steady state. Beta-2 receptor downregulation with continued use is also well documented, which is why most available protocols reference cycling and gradual dose adjustment rather than sustained fixed dosing at any concentration, particularly higher ones.

Every batch of CSD’s KlenSmart60 is third party lab tested for concentration accuracy and purity before being made available, with COA documentation available on request. CSD stocks Clenbuterol across 40mcg, 60mcg, and 80mcg oral tablet strengths plus a spray pen format, giving researchers dose range options that should be approached with appropriate caution and gradual titration rather than starting at higher strengths. All orders ship discreetly across Canada in plain, unmarked packaging with no identifying information on the exterior.

Clenbuterol carries a narrow margin between researched effects and significant cardiac risk, including tachycardia and potassium shifts that can be dangerous, particularly at higher doses or in combination with other stimulants. This product is not intended for human consumption. Consult a healthcare provider before considering use, and be aware of cardiac symptoms requiring immediate medical attention.

Store in a cool, dry place away from direct light and heat. Intended for research purposes only.